European Policy System Favoring Corporate Profits Over Public Health was Shaped by Tobacco Company

by Rajshri on  January 12, 2010 at 9:09 PM Corporate News
  •   Print
  •   Share
  •   Comments
  •  Text 
The European Union's framework for evaluating policy options was shaped by British American Tobacco (BAT), the world's second largest tobacco transnational, thus leading to the acceptance of an agenda which emphasizes business interests over public health, according to a study published in PLoS Medicine.

By law, virtually all new policies proposed in the European Union (EU) must undergo an "impact assessment" (IA): a review of the potential economic, social, and environmental consequences. The outcome of such review is heavily influenced by the type of impact assessment tool used. IA tools focusing on economic impacts, for example, tend to favor regulation increasing business profits, even if such policies undermine general public health. Independent experts have suggested that the EU's current IA tool, which focuses heavily on economic impacts, does not adequately take policies' health impacts into account.

Now, this new PLoS Medicine article provides evidence that BAT, working with companies from other sectors (including chemical, oil and food companies), played a key role in shaping the EU's current business-oriented IA system.

Dr Katherine Smith and colleagues (University of Bath; University of Edinburgh) analyzed over 700 internal BAT documents containing information on BAT's attempts to influence European regulatory reform, and interviewed relevant European policymakers and lobbyists. They found that BAT created a policy network comprised of representatives from a number of large corporations involved in marketing products that are damaging to public health and the environment, to promote a lobbying campaign to alter EU policymaking rules. The campaign resulted in specific changes to the EU Treaty calling for policymakers to reduce the regulatory burden on businesses, ultimately fostering the current system of business-oriented IA, which may well stall or even prevent future EU public health regulations, say the authors. Moreover, the authors report that EU officials were often unaware of the magnitude of BAT's influence—presumably due to the latter's creation of a policy network and the campaign's use of third parties, such as think tanks and consultancy companies.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

Corporate Related News

» Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod » Mylan’s ANDA for Clopidogrel Tablets Gets FDA Approval
» Drug Marketing: Abbott Labs Fined $1.6 Billion » The Cancer Cell Line Encyclopedia Launched by Novartis
» LeGoo Maker Pluromed to be Acquired by Sanofi » NGOs Protest Against Novartis' Glivec Lawsuit in India
» Allscripts Expanding India Operations » Bio-Tech Medicine Proves to be Attractive for TCG Lifesciences
Read More >>